Anti cancer drug certain anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Cell Line Neoplastic Stem Cells HeLa Cells Cells, Cultured

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases40

Neoplasms Radiation Injuries Breast Neoplasms Prostatic Neoplasms Colonic Neoplasms Lung Neoplasms Ovarian Neoplasms Neoplasms, Radiation-Induced Radiation Injuries, Experimental Stomach Neoplasms Neoplasm Metastasis Radiation Pneumonitis Pancreatic Neoplasms Neoplasm Invasiveness Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Carcinoma Uterine Cervical Neoplasms Adenocarcinoma Head and Neck Neoplasms Disease Progression Neoplasms, Experimental Colorectal Neoplasms Neoplasm Recurrence, Local Urinary Bladder Neoplasms Brain Neoplasms Cell Transformation, Neoplastic Genetic Predisposition to Disease Liver Neoplasms Neovascularization, Pathologic Rectal Neoplasms Acute Radiation Syndrome Melanoma Skin Neoplasms Esophageal Neoplasms Bone Neoplasms Endometrial Neoplasms Disease Models, Animal Mammary Neoplasms, Experimental Carcinoma, Small Cell

Chemicals and Drugs72

Antineoplastic Agents Doxorubicin Cisplatin Drug Carriers Antineoplastic Agents, Phytogenic Drugs, Investigational Neoplasm Proteins Antibiotics, Antineoplastic P-Glycoprotein Enzyme Inhibitors Naphthoquinones Protein Kinase Inhibitors Paclitaxel Radiation-Sensitizing Agents Tumor Markers, Biological Camptothecin Fluorouracil Pyrimidines Tumor Suppressor Protein p53 Etoposide Piperazines Plant Extracts RNA, Messenger Ellipticines RNA, Small Interfering Benzamides DNA Antimetabolites, Antineoplastic Cancer Vaccines Antibodies, Monoclonal DNA, Neoplasm Angiogenesis Inhibitors Anticarcinogenic Agents Prodrugs Organoplatinum Compounds Proto-Oncogene Proteins c-abl DNA Adducts Radiation-Protective Agents Proto-Oncogene Proteins c-bcl-2 DNA-Binding Proteins Caspases Caspase 3 Platinum Deoxycytidine Topoisomerase I Inhibitors Receptor, erbB-2 DNA Topoisomerases, Type II Daunorubicin Taxoids Mitomycin Antigens, Neoplasm Tumor Suppressor Proteins Antineoplastic Agents, Alkylating Nanocapsules Receptors, Estrogen Vinblastine Receptor, Epidermal Growth Factor Mitoxantrone Protein-Serine-Threonine Kinases Prostate-Specific Antigen Tamoxifen Cobalt Radioisotopes Proto-Oncogene Proteins c-akt Nuclear Proteins Multidrug Resistance-Associated Proteins Reactive Oxygen Species ATP-Binding Cassette Transporters Cell Cycle Proteins Bleomycin Guanine Histone Deacetylase Inhibitors Proto-Oncogene Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Radiation Dosage Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Drug Design Drug Delivery Systems Drug Discovery Molecular Targeted Therapy Radiation Monitoring Xenograft Model Antitumor Assays Drug Carriers Drug Approval Inhibitory Concentration 50 Clinical Trials as Topic Early Detection of Cancer Drug Evaluation, Preclinical Combined Modality Therapy Blotting, Western Radiotherapy Models, Biological Gene Expression Profiling Radiation Injuries, Experimental Models, Molecular Antineoplastic Combined Chemotherapy Protocols Radiotherapy Dosage Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Radiometry Survival Analysis Transplantation, Heterologous Survival Rate Retrospective Studies Prognosis Flow Cytometry Tumor Burden Follow-Up Studies Neoplasms, Experimental Neoplasm Staging Treatment Outcome Transfection Disease-Free Survival Prospective Studies Risk Radiotherapy, Adjuvant Risk Assessment Magnetic Resonance Spectroscopy Chemotherapy, Adjuvant Sensitivity and Specificity Phytotherapy Dose Fractionation Oligonucleotide Array Sequence Analysis Nanocapsules Registries Tumor Stem Cell Assay Risk Factors Polymerase Chain Reaction Reproducibility of Results Immunohistochemistry Drug Administration Schedule Radiotherapy Planning, Computer-Assisted Clinical Trials, Phase I as Topic Gene Knockdown Techniques Tomography, X-Ray Computed Disease Models, Animal Mammary Neoplasms, Experimental Radiation Hybrid Mapping Radiotherapy, Conformal Kaplan-Meier Estimate Odds Ratio

Phenomena and Processes54

Radiation Dosage Radiation, Ionizing Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Radiation Tolerance Apoptosis Radiation Cell Survival Cell Proliferation Gene Expression Regulation, Neoplastic Drug Resistance, Multiple Inhibitory Concentration 50 Molecular Structure Dose-Response Relationship, Drug Cell Cycle DNA Damage Signal Transduction Gamma Rays Cosmic Radiation Time Factors Structure-Activity Relationship Drug Synergism Ultraviolet Rays Background Radiation Mutation Cell Division DNA Repair Down-Regulation Radiation Effects Base Sequence Protein Binding DNA Adducts Transfection Risk Genetic Predisposition to Disease Cell Death Cell Growth Processes Stereoisomerism Phosphorylation Up-Regulation RNA Interference Sensitivity and Specificity Gene Expression X-Rays Genes, p53 Cell Movement Protein Structure, Tertiary Promoter Regions, Genetic DNA Methylation Enzyme Activation Gene Silencing Molecular Conformation Drug Resistance Odds Ratio

Disciplines and Occupations7

Drug Design Drug Discovery Radiation Oncology Medical Oncology Nanomedicine Radiobiology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Drug Approval United States Food and Drug Administration National Cancer Institute (U.S.)

Technology, Industry, Agriculture4

Drug Industry Nanoparticles Nanomedicine Nanocapsules

Information Science7

Pharmacopoeias as Topic Survival Rate Molecular Sequence Data Base Sequence Registries Radiotherapy Planning, Computer-Assisted Radiotherapy, Conformal

Named Groups1

Health Care34

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Clinical Trials as Topic Drug Costs United States Food and Drug Administration Fees, Pharmaceutical Cosmic Radiation Radiation Injuries, Experimental Cost Sharing Ultraviolet Rays Survival Analysis National Cancer Institute (U.S.)Survival Rate Retrospective Studies Follow-Up Studies Radiation Effects Treatment Outcome Disease-Free Survival Prospective Studies Risk Risk Assessment Sensitivity and Specificity Acute Radiation Syndrome Registries Radioactive Hazard Release Risk Factors Age Factors Reproducibility of Results Clinical Trials, Phase I as Topic Kaplan-Meier Estimate Odds Ratio

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Neoplasms Radiation Dosage Radiation, Ionizing Drug Screening Assays, Antitumor Cell Line, Tumor Drug Resistance, Neoplasm Radiation Injuries Dose-Response Relationship, Radiation Radiation Tolerance Drug Design Drug Delivery Systems Apoptosis Drug Discovery Radiation Molecular Targeted Therapy Cell Survival Breast Neoplasms Doxorubicin Mice, Nude Radiation Protection Radiation Monitoring Cell Proliferation Cisplatin Xenograft Model Antitumor Assays Gene Expression Regulation, Neoplastic Drug Resistance, Multiple Tumor Cells, Cultured Drug Carriers Drug Approval Inhibitory Concentration 50 Prostatic Neoplasms Antineoplastic Agents, Phytogenic Drugs, Investigational Molecular Structure Clinical Trials as Topic Early Detection of Cancer Neoplasm Proteins Dose-Response Relationship, Drug Radiation Oncology Colonic Neoplasms Drug Industry Cell Cycle Antibiotics, Antineoplastic P-Glycoprotein Lung Neoplasms Medical Oncology Ovarian Neoplasms Neoplasms, Radiation-Induced Drug Evaluation, Preclinical Enzyme Inhibitors DNA Damage Combined Modality Therapy Drug Costs Blotting, Western United States Food and Drug Administration Signal Transduction Radiotherapy Fees, Pharmaceutical Naphthoquinones Protein Kinase Inhibitors Gamma Rays Paclitaxel Cosmic Radiation Models, Biological Gene Expression Profiling Time Factors Radiation Injuries, Experimental Models, Molecular United States Antineoplastic Combined Chemotherapy Protocols Radiation-Sensitizing Agents Stomach Neoplasms Neoplasm Metastasis Tumor Markers, Biological Radiation Pneumonitis Pancreatic Neoplasms Cost Sharing Camptothecin Fluorouracil Pyrimidines Radiotherapy Dosage Pharmacopoeias as Topic Tumor Suppressor Protein p53 Neoplasm Invasiveness Neoplasm Transplantation Structure-Activity Relationship Etoposide Carcinoma, Squamous Cell Piperazines Drug Synergism Ultraviolet Rays Plant Extracts RNA, Messenger Ellipticines Background Radiation Reverse Transcriptase Polymerase Chain Reaction Radiometry Survival Analysis National Cancer Institute (U.S.)

No FAQ available that match "anti cancer drug certain anticancer drugs or radiation"